These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 10071035)

  • 1. Induction of specific tolerance to allografts in rats by therapy with non-mitogenic, non-depleting anti-CD3 monoclonal antibody: association with TH2 cytokines not anergy.
    Plain KM; Chen J; Merten S; He XY; Hall BM
    Transplantation; 1999 Feb; 67(4):605-13. PubMed ID: 10071035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.
    Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM
    Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4.
    Hall BM; Fava L; Chen J; Plain KM; Boyd RA; Spicer ST; Berger MF
    J Immunol; 1998 Nov; 161(10):5147-56. PubMed ID: 9820484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3-like monoclonal antibody.
    Nicolls MR; Aversa GG; Pearce NW; Spinelli A; Berger MF; Gurley KE; Hall BM
    Transplantation; 1993 Mar; 55(3):459-68. PubMed ID: 8456460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
    Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
    Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells.
    Lehmann M; Graser E; Risch K; Hancock WW; Müller A; Kuttler B; Hahn HJ; Kupiec-Weglinski JW; Brock J; Volk HD
    Transplantation; 1997 Oct; 64(8):1181-7. PubMed ID: 9355837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymus-dependent, anti-CD4-induced tolerance to rat cardiac allografts.
    Jaques BC; Ahmiedat H; Alastair Gracie J; Marshall HE; Middleton SE; Bolton EM; Bradley JA
    Transplantation; 1998 Nov; 66(10):1291-9. PubMed ID: 9846511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft-infiltrating T helper cells, CD45RC phenotype, and Th1/Th2-related cytokines in donor-specific transfusion-induced tolerance in adult rats.
    Josien R; Pannetier C; Douillard P; Cantarovich D; Menoret S; Bugeon L; Kourilsky P; Soulillou JP; Cuturi MC
    Transplantation; 1995 Nov; 60(10):1131-9. PubMed ID: 7482721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)1 cells that is augmented by IL-4.
    Tran GT; Carter N; He XY; Spicer TS; Plain KM; Nicolls M; Hall BM; Hodgkinson SJ
    Int Immunol; 2001 Sep; 13(9):1109-20. PubMed ID: 11526091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intragraft cytokine mRNA expression in rejecting and non-rejecting vascularized xenografts.
    Lorant T; Krook H; Wilton J; Olausson M; Tufveson G; Korsgren O; Johnsson C
    Xenotransplantation; 2003 Jul; 10(4):311-24. PubMed ID: 12795680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta production.
    Chavin KD; Qin L; Lin J; Woodward JE; Baliga P; Bromberg JS
    Ann Surg; 1993 Oct; 218(4):492-501; discussion 501-3. PubMed ID: 8215640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
    Chavin KD; Qin L; Lin J; Yagita H; Bromberg JS
    J Immunol; 1993 Dec; 151(12):7249-59. PubMed ID: 7903105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of tolerance with nondepleting anti-CD4 monoclonal antibodies is associated with down-regulation of TH2 cytokines.
    Plain KM; Fava L; Spinelli A; He XY; Chen J; Boyd R; Davidson CL; Hall BM
    Transplantation; 1997 Dec; 64(11):1559-67. PubMed ID: 9415556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of a clinically relevant protocol to induce tolerance of cardiac allografts. Perioperative donor spleen cells plus cyclosporine suppress IL-2 and interferon-gamma production.
    Salom RN; Maguire JA; Hancock WW
    Transplantation; 1993 Dec; 56(6):1309-14. PubMed ID: 8278994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement.
    Punch JD; Tono T; Qin L; Bishop DK; Bromberg JS
    J Immunol; 1998 Aug; 161(3):1156-62. PubMed ID: 9686574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides.
    Shirwan H; Barwari L; Khan NS
    Transplantation; 1998 Dec; 66(12):1802-9. PubMed ID: 9884279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absent mRNA accumulation of Th1 or Th2 cytokines in heart allografts with chimerism-based drug-induced tolerance.
    Tomita Y; Zhang QW; Matsuzaki G; Shimizu I; Iwai T; Okano S; Nomoto K; Yasui H
    Surg Today; 2005; 35(5):364-70. PubMed ID: 15864417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of Th1- and Th2-type cytokine profiles in anti-CD2 monoclonal antibody-induced tolerance.
    Krieger NR; Most D; Bromberg JS; Holm B; Huie P; Sibley RK; Dafoe DC; Alfrey EJ
    Transplantation; 1996 Nov; 62(9):1285-92. PubMed ID: 8932273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-specific tolerance by perioperative intrathymic injection of bone marrow cells in the rat cardiac allograft model: use of FK506 can shorten the necessary duration of pretransplant intrathymic conditioning.
    Ito A; Ito T; Kamiike W; Moriguchi A; Ohkawa A; Uchikoshi F; Tanaka S; Nakata S; Matsuda H
    Transplantation; 1997 Sep; 64(5):752-7. PubMed ID: 9311715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.